As a Florida Avandia claims lawyer who represents consumers injured by the Diabetes drug Avandia, I was pleased to learn that GlaxoSmithKline issued a statement that they were halting the recruitment of patients for a so called TIDE trial. In other words, they are not looking for more people to subject to this dangerous drug for clinical trials. However, they have not agreed to halt those that are participating in ongoing trials.
Seems to me, that is is a reckless and callous indifference to the well being of those participating in Avandia trials. Why cannot the FDA step in and order the trials be stopped until such time as either Avandia is proven safe or is completely withdrawn from the market?
Once again, the FDA proves to me to be too slow and too conservative in its efforts to protect consumers from defective drugs. I suggest that any one who is currently taking Avandia or is considering it, immediately speak to your health care provider about the latest research and about alternate diabetes drugs.
